BIOGEN INC (BIIB)
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Director information for BIIB
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| BIIB | Independent Chair (after 2026 Annual Meeting) | 71 | ["Executive Leadership and Business Operations","Drug Development","Healthcare and Pharma Leadership","Finance and Accounting","International Business","Public Board Service","Government and Public Policy","Medicine and Scientific Research","Significant knowledge and experience with respect to medical research","Expertise in pharmaceutical industry and government healthcare policymaking","Strong public policy and government experience"] | ["Compensation and Management Development","Corporate Governance"] | 2026 |
Companies shown below are based on exact name match for the selected Director
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| EXEL | Independent Director | 71 | ["Training as a scientist","Knowledge and experience in U.S. and global public health","Experience in the biopharmaceutical industry and government healthcare policymaking","Leadership experience in the public sector","Former President and Executive Director, Foundation for the National Institutes of Health","Former President and member of the board of directors of the Albert and Mary Lasker Foundation","Former President and CEO of the TB Alliance","Director of the Office of Technology Transfer at the National Institutes of Health"] | ["Governance Committee","Research & Development Committee"] | 2026 |
| ARE | Prior President and Executive Director of Foundation for the National Institutes of Health | 67 | ["Expert in technology commercialization", "President and Executive Director of The Foundation for the National Institutes of Health", "President of the Albert and Mary Lasker Foundation", "President and Chief Executive Officer of the Global Alliance for TB Drug Development", "Directed the Office of Technology Transfer at the NIH", "Commissioner on WHO\u2019s Commission on Intellectual Property Rights, Innovation and Public Health", "Member of U.S. National Academy of Medicine", "Member of the Council on Foreign Relations"] | [] | 2022 |
Biography sourced from the proxy statement filing.
Independent Chair (after 2026 Annual Meeting), fmr. President and Executive Director, Foundation for the National Institutes of Health Director since 2021 Age 71 Board Committees Compensation and Management Development Corporate Governance Key Skills Executive Leadership and Business Operations Drug Development Healthcare and Pharma Leadership Finance and Accounting International Business Public Board Service Government and Public Policy Medicine and Scientific Research Relevant Expertise Dr. Freire has significant knowledge and experience with respect to medical research, the pharmaceutical industry and government healthcare policymaking. Dr. Freire s strong public policy and government experience vitally enhances the Board s perspective of significant issues affecting the highly regulated life sciences industry. Career Highlights President and Executive Director, Foundation for the National Institutes of Health (NIH) (2012 2021) President and Director, Albert and Mary Lasker Foundation (2008 2012) President and CEO, Global Alliance for TB Drug Development (2001 2008) Director of the Office of Technology Transfer, NIH (1995 2001) Other Public Company Boards Current Alexandria Real Estate Equities, Inc. (since 2012) Exelixis, Inc. (since 2018) Other Boards & Awards Science Board of the U.S. Food and Drug Administration (FDA) World Health Organization Commission on Intellectual Property Rights, Innovation and Public Health, United Nations Secretary General s High-Level Panel on Access to Medicines Member, National Academy of Medicine and the Council on Foreign Relations 2017 Gold Stevie Award for Woman of the Year, the U.S. Department of Health and Human Services Secretary s Award for Distinguished Service, the Arthur S. Fleming Award and the Bayh-Dole Award Education B.S. from the Universidad Peruana Cayetano Heredia (Lima, Peru) Ph.D. in Biophysics from the University of Virginia